Table 1.

Summary Code Descriptions From Oncology Practices Versus CMS Instructions

Code	CMS Instructions	Selected Examples From Site Visits
G9071 (breast cancer, female)	Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage I or stage IIA-IIB; or T3, N1, M0; and ER and/or PR positive; with no evidence of disease progression, recurrence, or metastases	Onc Dx brst Stg 1-2B no dx pr
G9077 (prostate cancer)	Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; T1-T2C and Gleason 2-7 and PSA ≤ 20 at diagnosis with no evidence of disease progression, recurrence, or metastases	Onc Dx prostate T1 no progress
G9065 (non-small cell lung cancer)	Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage IIIA (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases	NSCLC Stage IIIA, stable

Abbreviations: CMS, Centers for Medicare & Medicaid Services; ER, estrogen receptor; PR, progesterone receptor; PSA, prostate-specific antigen.